// App-Quantinova.ai

Mo1659 : Inpatient Status, Severe Clostridium difficile Infection and Immunocompromised State Predict Failure Despite Multiple Fecal Microbiota Transplants: A Multicenter Study

Researchers

Presenter

  • Colleen R. Kelly

Principal Investigators

  • Dina Kao

  • Joseph Dimitry

  • Tracey Martin

  • Jessica R. Allegretti

  • Huiping Xu

  • Monika Fischer

Medical Centers

  • Medicine/Gastroenterology, IUPUI, Indianapolis, Indiana, United States

  • Hepatology, University of Alberta, Edmonton, Alberta, Canada

  • Gastroenterology, Brigham and Women, Boston, Massachusetts, United States

  • Brown Medical School, Butler Hospital, Providence, Rhode Island, United States

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Clostridium difficile infection

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved